Natco Pharma announces drug donation program

Natco Pharma Ltd has announced an ambitious drug access program.

The Company takes this opportunity to reiterate that it already has a well established and running drug access program for its brand - Veenat - the medicine for blood cancer (chronic myeloid leukemia).

As a continuation of this program, the Company has decided to support 10,000 breast cancer patients with free supply of generic version of Arimidex Anastrazole. The supplies would be made through select cancer research institutes / cancer hospitals all over the country. Internationally priced at US $ 5 per tablet, patients are required to take one tablet each day.

Source : Equity Bulls

Keywords